Morales-Aranda JJ, Vázquez-Niño CL, Gutiérrez-Rosales R, Aragón-Castro MA, Ruvalcaba-Oceguera GE

Language: Spanish
References: 16
Page: 238-243
PDF size: 186.47 Kb.

ABSTRACT

Sexual development disorders have a low incidence in the pediatric population, but given their intermediate and long-term impact on the life of the patients, they need to be understood. Embryonic testicular regression syndrome is a complex entity that is often unperceived in the medical diagnosis. It is characterized by embryonic exposure to testosterone stimulus, but at some point of development, gonadal regression occurs, resulting in or expressing varying degrees of the masculine phenotype. Diagnosis is made through the detection of the 46, XY karyotype and the determination of castration levels of testosterone, as well as elevated serum luteinizing hormone and follicle-stimulating hormone levels. Serum concentration of the anti-Müllerian hormone is useful as an indirect marker of testicular presence and function. When levels are normal or increased, an androgenic synthesis disorder should be suspected, and embryonic testicular regression syndrome excluded. Management is controversial, because it is individualized according to the degree of phenotypic virilization, but it should always be multidisciplinary. Psychologic support is essential for both the patient and parents.

REFERENCES

1. Rey RA, Grinspan R. Normal male sexual differentiation and aetiology of disorders of sex development. Best Pract Res Clin Endocrinol Metabol. 2011;25:221-238.

2. Sajjad Y: Development of the genital ducts and external genitalia in the early human embryo. J Obstet Gynaecol Res 2010; 36:929.

3. Philibert P, Zenaty D, Lin L, et al. Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study. Hum Reprod 2007;22:3255-61.

4. Cohen-Kettenis P. Psychological long-term outcome in intersex conditions. Horm Res 2005;64(Suppl.):27.

5. Migeon CJ. Comments about the need for prenatal treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1990;70:836-7.

6. Sutcliffe JR, Wilson-Storey D, Smith NM. Ante-natal testicular torsion: only one cause of the testicular regression syndrome? J R Coll Surg Edinb 1996;41:99-101.

7. Calogero AE, Garofalo MR, Barone N, De Palma A, Vicari E, Romeo R, et al. Spontaneous regression over time of the germinal epithelium in a Y chromosome-microdeleted patient: case report. Hum Reprod 2001;16:184-185.

8. Lambert SM, Vilain EJ, Kolon TF: A practical approach to ambiguous genitalia in the newborn period. Urol Clin N Am 2010;37:195 2.

9. Huhtaniemi IT. The role of mutations affecting gonadotrophin secretion and action in disorders of pubertal development. Best Pract Res Clin Endocrinol Metabol. 2002;16:123-138.

10. Thompson ST, Grillis MA, Wolkoff LH & Katzin WE. Transverse testicular ectopia in a man with persistent Müllerian duct syndrome. Arch Pathol Lab Med. 1994;118:752-755.

11. Lee YS, Kirk JM, Stanhope RG, et al. Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clin Endocrinol 2007;67:20-28.

12. Miller WL, Huang N, Agrawal V, Giacomini KM. Genetic variation in human P450 oxidoreductase. Mol Cell Endocrinol 2009;300:180-184.

13. Giordano SJ, Kaftory A, Steggles AW. A splicing mutation in the cytochrome b5 gene from a patient with congenital methemoglobinemia and pseudohermaphrodism. Human Genetics. 1994;93:568-570.

14. Hughes IA, Morel Y, McElreavey K, et al. Biological assessment of abnormal genitalia. J Pediatr Urol 2012;8:592-6.

15. Thyen U, Lanz K, Holterhus P, et al. Epidemiology and initial management of ambiguous genitalia at birth in Germany. Hormone Res 2006;66:195e203.

16. Parisi MA, Ramsdell LA, Burns MW, et al. A Gender Assessment Team: experience with 250 patients over a period of 25 years. Genet Med 2007;9:348.